参考文献/References:
[1] Vahanian A,Beyersdorf F,Praz F,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J,2021,60(4):727-800.
[2] Otto CM,Nishimura RA,Bonow RO,et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. Circulation,2021,143(5):e35-e71.
[3] Généreux P,Head SJ,Van Mieghem NM,et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions:a weighted meta-analysis of 3,519 patients from 16 studies[J]. J Am Coll Cardiol,2012,59(25):2317-2326.
[4] Kappetein AP,Head SJ,Généreux P,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation:the Valve Academic Research Consortium-2 consensus document (VARC-2) [J]. Eur J Cardiothorac Surg,2012,42(5):S45-S60.
[5] Arai T,Lefèvre T,Hovasse T,et al. Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world[J]. Catheter Cardiovasc Interv,2017,90(7):1192-1197.
[6] Khatri PJ,Webb JG,Rodés-Cabau J,et al. Adverse effects associated with transcatheter aortic valve implantation:a meta-analysis of contemporary studies[J]. Ann Intern Med,2013,158(1):35-46.
[7] Ribeiro HB,Webb JG,Makkar RR,et al. Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry[J]. J Am Coll Cardiol,2013,62(17):1552-1562.
[8] Dvir D,Webb J,Brecker S,et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves:results from the global valve-in-valve registry[J]. Circulation,2012,126(19):2335-2344.
[9] Jabbour RJ,Tanaka A,Finkelstein A,et al. Delayed coronary obstruction after transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2018,71(14):1513-1524.
[10] Holmes DR Jr,Mack MJ,Kaul S,et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2012,59(13):1200-1254.
[11] Achenbach S,Delgado V,Hausleiter J,et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR) [J]. J Cardiovasc Comput Tomogr,2012,6(6):366-380.
[12] Ribeiro HB,Nombela-Franco L,Urena M,et al. Coronary obstruction following transcatheter aortic valve implantation:a systematic review[J]. JACC Cardiovasc Interv,2013,6(5):452-461.
[13] Buellesfeld L,Stortecky S,Kalesan B,et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2013,6(1):72-83.
[14] Webb JG,Wood DA,Ye J,et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves[J]. Circulation,2010,121(16):1848-1857.
[15] Webb JG,Dvir D. Transcatheter aortic valve replacement for bioprosthetic aortic valve failure:the valve-in-valve procedure[J]. Circulation,2013,127(25):2542-2550.
[16] Barbanti M,Webb JG,Tamburino C,et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure[J]. Circ Cardiovasc Interv,2016,9(9):e003930.
[17] Ribeiro HB,Nombela-FrancoL,AllendeR,et al. Coronary obstruction following transcatheter aortic valve implantation for degenerative bioprosthetic surgical valves:a systematic literature review[J]. Rev Bras Cardiol Invasiva,2013,21(4):311-318.
[18] Bernardi FLM,Dvir D,Rodes-Cabau J,et al. Valve-in-valve challenges:how to avoid coronary obstruction[J]. Front Cardiovasc Med,2019,6:120.
[19] Lederman RJ,Babaliaros VC,Rogers T,et al. Preventing coronary obstruction during transcatheter aortic valve replacement:from computed tomography to BASILICA[J]. JACC Cardiovasc Interv,2019,12(13):1197-1216.
[20] Fassa AA,Himbert D,Vahanian A. Mechanisms and management of TAVR-related complications[J]. Nat Rev Cardiol,2013,10(12):685-695.
[21] Zamorano JL,Goncalves A,Lang R. Imaging to select and guide transcatheter aortic valve implantation[J]. Eur Heart J,2014,35(24):1578-1587.
[22] Oh JH,Kobayashi Y,Kang G,et al. Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR[J]. Int J Cardiol Heart Vasc,2021,37:100917.
[23] Heitkemper M,Hatoum H,Azimian A,et al. Modeling risk of coronary obstruction during transcatheter aortic valve replacement[J]. J Thorac Cardiovasc Surg,2020,159(3):829-838.e3.
[24] Garot P. TAVR-related coronary obstruction:preventive wires or stenting?[J]. JACC Cardiovasc Interv,2020,13(6):748-750.
[25] Banno H,Cochennec F,Marzelle J,et al. Comparison of fenestrated endovascular aneurysm repair and chimney graft techniques for pararenal aortic aneurysm[J]. J Vasc Surg,2014,60(1):31-39.
[26] Mercanti F,Rosseel L,Neylon A,et al. Chimney stenting for coronary occlusion during TAVR:insights from the chimney registry[J]. JACC Cardiovasc Interv,2020,13(6):751-761.
[27] Palmerini T,Chakravarty T,Saia F,et al. Coronary protection to prevent coronary obstruction during TAVR:a multicenter international registry[J]. JACC Cardiovasc Interv,2020,13(6):739-747.
[28] Khan JM,Dvir D,Greenbaum AB,et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement:concept to first-in-human[J]. JACC Cardiovasc Interv,2018,11(7):677-689.
[29] Kitamura M,Majunke N,Holzhey D,et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction:feasibility and early clinical outcomes of the BASILICA technique[J]. EuroIntervention,2020,16(8):682-690.
[30] Khan JM,Greenbaum AB,Babaliaros VC,et al. BASILICA trial:one-year outcomes of transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction[J]. Circ Cardiovasc Interv,2021,14(5):e010238.
[31] Ye J,Lee AJ,Blanke P,et al. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction [J]. Catheter Cardiovasc Interv,2018,92(6):1209-1214.
[32] Shi J,Wei L,Chen Y,et al. Transcatheter aortic valve implantation with J-Valve:2-year outcomes from a multicenter study[J]. Ann Thorac Surg,2021,111(5):1530-1536.
[33] Geisbusch S,Bleiziffer S,Mazzitelli D,et al. Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation[J]. Circ Cardiovasc Interv,2010,3(6):531-536.
[34] Fiorina C,Curello S,Maffeo D,et al. Management of acute left main obstruction after transcatheter aortic valve replacement:the "tunnel technique"[J]. Cardiovasc Revasc Med,2012,13(2):142.e5-142.e9.
[35] Singh V,Yarkoni A,O’Neill WW. Emergent use of Impella CPTM during transcatheter aortic valve replacement:Transaortic access[J]. Catheter Cardiovasc Interv,2015,86(1):160-163.
相似文献/References:
[1]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[2]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[3]刘新民 宋光远 吴永健.左心室导丝起搏技术在经导管主动脉瓣置换术中的应用[J].心血管病学进展,2021,(4):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
LIU Xinmin,SONG Guangyuan,WU Yongjian.Application of Left Ventricular Guidewire Pacing in Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2021,(5):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
[4]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(5):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[5]陈阳 赵庆豪 赵杰 吴永健.经导管主动脉瓣置换术时代慢性主动脉瓣反流诊治进展[J].心血管病学进展,2022,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
CHEN Yang,ZHAO Qinghao,SONG Guangyuan,et al.Diagnosis and Treatment of Chronic Aortic Regurgitation in Transcatheter Aortic Valve Replacement Era[J].Advances in Cardiovascular Diseases,2022,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
[6]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(5):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[7]张木馨 李丽英 阮海燕 何森.经导管主动脉瓣置换术后抗栓治疗进展[J].心血管病学进展,2022,(6):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
ZHANG Muxin,LI Liying,RUAN Haiyan,et al.Progress of Antithrombotic Therapy after?ranscatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
[8]. 经导管主动脉瓣置换术术后抗栓治疗的研究进展 [J].心血管病学进展,2022,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
DUAN ZhenyaWU Yongjian.Antithrombotic Therapy After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(5):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[10]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(5):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]